Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth
NAV: 28 Aug '26
₹12.74
Min. for SIP
₹500
Fund size (AUM)
₹46.82 Cr
Expense ratio
0.79%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,487 | +3.25% | |
| 6 months | ₹30,000 | ₹32,914 | +9.71% | |
| 1 year | ₹60,000 | ₹68,795 | +14.66% |
Holdings (31)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Laurus Labs Ltd | Healthcare | Equity | 10.77% |
| Lupin Ltd | Healthcare | Equity | 8.94% |
| Fortis Healthcare Ltd | Healthcare | Equity | 7.50% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 6.66% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 5.13% |
| Alkem Laboratories Ltd | Healthcare | Equity | 5.13% |
| Biocon Ltd | Healthcare | Equity | 4.63% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.26% |
| Ipca Laboratories Ltd | Healthcare | Equity | 3.70% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.18% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 3.17% |
| Gland Pharma Ltd | Healthcare | Equity | 3.04% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.76% |
| Neuland Laboratories Ltd | Healthcare | Equity | 2.50% |
| Wockhardt Ltd | Healthcare | Equity | 2.47% |
| Ami Organics Ltd | Healthcare | Equity | 2.45% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 2.26% |
| Ajanta Pharma Ltd | Healthcare | Equity | 2.22% |
| Abbott India Ltd | Healthcare | Equity | 2.21% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 2.14% |
| Onesource Specialty Pharma Ltd | Healthcare | Equity | 1.94% |
| Piramal Pharma Ltd | Healthcare | Equity | 1.85% |
| Global Health Ltd | Healthcare | Equity | 1.83% |
| Granules India Ltd | Healthcare | Equity | 1.82% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 1.67% |
| Natco Pharma Ltd | Healthcare | Equity | 1.26% |
| Syngene International Ltd | Healthcare | Equity | 1.12% |
| Pfizer Ltd | Healthcare | Equity | 1.11% |
| Suven Pharmaceuticals Ltd | Healthcare | Equity | 1.05% |
| Poly Medicure Ltd | Healthcare | Equity | 0.99% |
| Net Receivables | Unspecified | Net Receivables | 0.24% |
See All
Minimum investments
Min. for 1st investment
₹500
Min. for 2nd investment
₹500
Min. for SIP
₹500
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +8.9% | +19.7% | +20.9% | +27.4% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 19 | 12 | 11 | -- |
Exit load, stamp duty and tax
Exit load
Exit load of 1%, if redeemed within 15 days.
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
SPMSwapnil P MayekarOct 2024 - PresentView details
SPM
Swapnil P Mayekar
Oct 2024 - Present
View details
RSRakesh ShettyOct 2024 - PresentView details
RS
Rakesh Shetty
Oct 2024 - Present
View details
DMDishant MehtaDec 2024 - PresentView details
DM
Dishant Mehta
Dec 2024 - Present
View details
About Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth is a Equity Mutual Fund Scheme launched by Motilal Oswal Mutual Fund. This scheme was made available to investors on 29 Dec 2009. Swapnil P Mayekar is the Current Fund Manager of Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,55,306 Cr and the Latest NAV as of 28 Aug 2026 is ₹12.74.
The Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹500. Minimum Lumpsum Investment is ₹500. Exit load of 1%, if redeemed within 15 days.
;
Investment Objective
The scheme seeks to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.
Fund benchmarkNifty MidSmall Healthcare Total Return Index
Fund house
Rank (total assets)#19 in India
Total AUM₹1,55,305.63 Cr
Date of Incorporation29 Dec 2009
Launch Date29 Dec 2009
AddressMotilal Oswal Towers - 10th Floor,Rahimtullah Sayani Road,Opposite Parel ST Depot, Prabhadevi, Mumbai 400025
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,